The caveat here is that if one is opting for rhythm control to avoid the need for warfarin in this elderly population, that is not a valid assumption. How should one manage atrial fibrillation ...

Researchers sought to determine 1-year outcomes in patients being treated with tirzepatide who have atrial fibrillation.

a “rate control” strategy and a “rhythm control” strategy. In 2002, the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) randomized trial evaluated the outcomes of ...

the findings emphasize the importance of aggressive AFib management, particularly in younger patients who might otherwise receive less intensive treatment due to their age. Rhythm control ...

Boston Scientific, Medtronic, Abbott and J&J unveiled new data for their PFA devices in tandem with the Heart Rhythm ...

Atrial fibrillation (AFib) is the most common abnormal heart rhythm found in our community. According to the CDC website, an estimated 12 million people in the United States will have atrial ...

(European Journal of Preventive Cardiology) The available observational data point to dronedarone being better than sotalol as a first-line anti-arrhythmic drug for rhythm control in Afib.

You may be able to lower your risk for developing heart rhythm abnormalities by speeding ... Nearly 60 million people worldwide have atrial fibrillation, according to a 2024 study.

Additionally, longitudinal studies that assess the impact of early intervention for [atrial fibrillation], including rhythm control and management of cardiovascular risk factors, are needed to ...

There are improved all-cause mortality, rhythm control, and adverse cardiac event outcomes in patients being treated with tirzepatide who have atrial fibrillation. Patients with atrial ...

The procedure is becoming physicians’ preferred ablation method for treating atrial fibrillation, an irregular rhythm that can lead to complications such as blood clots, stroke and heart failure.